[ 11C]choline PET for the intraprostatic tumor characterization and localization in recurrent prostate cancer after EBRT

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 56, Issue 2, 2012, Pages 202-208

  Rybalov, M ^a   Breeuwsma, A J ^a   Pruim, J ^a   Leliveld, A M ^a   Rosati, S ^a   Veltman, N C ^a   Dierckx, R A ^a   De Jong, I J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Neoplasm recurrence, local; Positron emission tomography; Prostate neoplasms

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN; CARBON; CHOLINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; STUDENT T TEST; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

AGED; CARBON RADIOISOTOPES; CHOLINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84864390073     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics. CA Cancer J Clin 2008;58:71-96.
2. Zagars GK, Pollack A, von Eschenbach AC. Prognostic factors for clinically localized prostate carcinoma, analysis of 938 patients irradiated in the prostate specific antigen era. Cancer 1997;79:1370-80. (Pubitemid 27143245)
3. Zietman AL, Coen JJ, Dallow KC, Shipley WU. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int J Radiat Oncol Biol Phys 1995;32:287-92.
4. De La Taille A, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int 2000;85:281-6. (Pubitemid 30088519)
5. Zagars GK. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. J Urol 1994;152(5 Pt 2):1786-91. (Pubitemid 24322630)
6. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007;4:632-42. (Pubitemid 350020378)
7. Kane CJ, Amling CL, Johnstone PA, Pak N, Lance RS, Thrasher JB et al. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology 2003;61:607-11. (Pubitemid 36294200)
8. 18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169:1337-40.
9. 11C]-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 2003;44:32-8.
10. 11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer. BJU Int 2007;100:786-93.
11. Krause BJ, Souvatzoglou M, Tuncel M, Herrmann K, Buck AK, Praus C et al. The detection rate of [(11)C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35:18-23. (Pubitemid 350234152)
12. Farsad M, Schiavina R, Franceschelli A, Sanguedolce F, Castellucci P, Bertaccini A et al. Positron-emission tomography in imaging and staging prostate cancer. Cancer Biomark 2008;4:277-84.
13. 11C]-choline positron emission tomography (PET). Int J Radiat Oncol Biol Phys 2010;77:160-4.
14. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP et al. EAU guidelines on prostate cancer. Eur Urol 2008;53:68-80. (Pubitemid 350166735)
15. Hara T. [11C]-choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol 2002;4:267-73. (Pubitemid 35214587)
16. Schilling D, Schlemmer HP, Wagner PH, Böttcher P, Merseburger AS, Aschoff P et al. Histological verification of [11C)-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 2008;102:446-51. (Pubitemid 352032836)
17. Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33:1387-98. (Pubitemid 44885404)
18. Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:425-30.
19. Farsad M, Schiavina R, Castellucci P. Detection and localization of Prostate cancer: correlation of [11]C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 2005;46:1642-9. (Pubitemid 46211588)
20. Crawford ED, Wilson SS, Torkko KC, Hirano D, Stewart JS, Brammell C et al. Clinical staging of prostate cancer: A computer-simulated study of transperineal prostate biopsy. BJU Int 2005;96:999-1004. (Pubitemid 41531402)
21. Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008;26:506-10.
22. Chiong E, Andino L, Guo CC, Prokhorova IN, Goh JJK, Pisters LL et al. Pathologic features of salvage radical prostatectomy specimens following radiotherapy: implications for focal therapeutic options. J Urol 2009;181(Suppl 1):458.
23. Heidenreich A, Semrau R, Thüer D, Pfister D. Radical salvage prostatectomy: Treatment of local recurrence of prostate cancer after radiotherapy. Urologe A 2008; 47:1441-6.
24. Ohlmann C, Pfister D, Thüer D, Wille S, Engelmann UH, Heidenreich A. [11C]-choline Positron Emission Tomography/Computerized Tomography for tumor localization of locally recurrent prostate cancer after radiation therapy. Eur Urol Suppl 2007;6:229.
25. Holzapfel K, Müller SA, Seidl C, Grosu AL, Schwaiger M, Senekowitsch-Schmidtke R. Effects of irradiation on the [Methyl-3H] choline uptake in the human prostate cancer cell lines LNCaP and PC3. Strahlenther Onkol 2008;184:319-24. (Pubitemid 351806517)